BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Julphar
AstraZeneca
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission
Medtronic
Baxter
McKinsey
McKesson

Generated: January 23, 2018

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Lidocaine Hydrochloride patents expire, and when can generic versions of Lidocaine Hydrochloride launch?

Lidocaine Hydrochloride is a drug marketed by Abbott, Abraxis Pharm, Akorn, Aurobindo Pharma Ltd, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Gd Searle Llc, Hospira, Intl Medication, Luitpold, Luitpold Pharms Inc, Lyphomed, Miles, Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, G And W Labs Inc, Watson Labs Inc, Hi Tech Pharma, Wockhardt, Paco, Teligent Pharma Inc, Vintage, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Fresenius Kabi Usa, and Actavis Mid Atlantic. and is included in ninety-four NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Drug patent expirations by year for LIDOCAINE HYDROCHLORIDE
Pharmacology for LIDOCAINE HYDROCHLORIDE
Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare LIDOCAINE HYDROCHLORIDE 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018461-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089646-001 Jun 21, 1988 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Luitpold LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 080850-001 Approved Prior to Jan 1, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 088294-001 May 17, 1984 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Baxter Hlthcare LIDOCAINE HYDROCHLORIDE 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018461-004 Feb 22, 1982 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurobindo Pharma Ltd LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE lidocaine hydrochloride INJECTABLE;INJECTION 203082-001 Mar 14, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 085463-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 091058-001 Sep 30, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 088367-001 Jul 31, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Ayerst LIDOCAINE HYDROCHLORIDE lidocaine hydrochloride INJECTABLE;INJECTION 083083-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
UBS
US Army
Argus Health
Queensland Health
Cipla
Farmers Insurance
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot